Abstract:377 Background: Activation and clonal expansion of tumor antigen-specific T cells in cancer patients are crucial for immunotherapies. Recent reports indicate that CD39 is a marker to distinguish tumor-reactive CD8 T cell populations from bystander populations. In gastric cancer (GC), anti-CD39 antibody, anti-PD-1 antibody, and FOLFOX combination therapy may be effective therapy at AACR 2022. Methods: We retrospectively reviewed the data of 62 GC patients who underwent gastrectomy at our hospital (2017 - 2018) and examined their rejected specimen’s immune-microenvironment using immunohistochemistry. Then we prospectively enrolled 16 GC patients. Their tumor tissue and tumor-infiltrating lymphocytes (TILs) were extracted from surgical specimens, these fractions were subjected to the RNA-seq analysis ( n = 3), CD107a degranulation assay ( n = 7) and 3H-Thymidine incorporation assay ( n = 7). Results: The densities of CD39 + CD8 TILs positively correlated with the densities of CD4 T cells and B-cells in GC tissues ( P = 0.01, < 0.01, respectively). Furthermore, higher densities of CD39 + CD8 TILs in GC patients were associated with better overall survival ( P < 0.01). We classified TILs into four groups based on expression levels of the PD-1 and CD39. The proportion of CD39 + CD8 T cells was significantly higher in GC tissues than their PBMCs ( n = 13) and non-cancerous tissues ( n = 4). CD39 + PD-1 + CD8 (DP) TILs in primary tumors were elevated expression of multiple inhibitory receptors such as LAG3, TIGIT and reduced expression of IL-2 by RNA-seq analysis. T cells expanded in vitro from DP-TILs ( n = 5) efficiently recognized autologous tumor cells in CD107a assay compared with other populations, and considered to be tumor-reactive T cells fraction. However, since these DP TILs in primary tumors show exhausted phenotypes, capacities to kill tumor are expected to be reduced in the tumor-microenvironment (TME). By adding ATP to the DP-TILs in vitro at the concentration reported in the TME, we observed reduction of cell proliferation by 3H-thymidene incorporation assay and of degranulation by CD107a assay, and we observed recovery of these changes by adding anti-CD39 inhibitory antibody. Conclusions: DP-TILs may have superior T cell receptors recognizing tumor-antigens and contribute to tumor eradication, especially when administrated anti-CD39 antibody.

Tumor-infiltrating CD39+ γδTregs are novel immunosuppressive T cells in human colorectal cancer

In situ analysis of FOXP3+ regulatory T cells and myeloid dendritic cells in human colorectal cancer tissue and tumor-draining lymph node.

Intratumoral FoxP3+Helios+ Regulatory T Cells Upregulating Immunosuppressive Molecules Are Expanded in Human Colorectal Cancer

CD8+CXCR5+ T Cells in Tumor-Draining Lymph Nodes Are Highly Activated and Predict Better Prognosis in Colorectal Cancer.

Human hepatocellular carcinoma-infiltrating CD4 + CD69 + Foxp3 − regulatory T cell suppresses T cell response via membrane-bound TGF-β1

CD39 Transforming Cancer Therapy by Modulating Tumor Microenvironment

CD39 expression defines exhausted CD4+ T cells associated with poor survival and immune evasion in human gastric cancer

Potential Role of Plasmacytoid Dendritic Cells for FOXP3+ Regulatory T Cell Development in Human Colorectal Cancer and Tumor Draining Lymph Node.

High Expression of CD39 in Gastric Cancer Reduces Patient Outcome Following Radical Resection.

Γδt17 Cells Promote the Accumulation and Expansion of Myeloid-Derived Suppressor Cells in Human Colorectal Cancer.

Tumor-infiltrating gamma delta T-cells reveal exhausted subsets with remarkable heterogeneity in colorectal cancer

Increased tumor-infiltrating CD45RA − CCR7 − regulatory T-cell subset with immunosuppressive properties foster gastric cancer progress

Accumulation Of Foxp3(+) T Regulatory Cells In Draining Lymph Nodes Correlates With Disease Progression And Immune Suppression In Colorectal Cancer Patients

FOXP3+ Tregs: Heterogeneous Phenotypes and Conflicting Impacts on Survival Outcomes in Patients with Colorectal Cancer

Tumor-derived immunoglobulin like transcript 5 induces suppressive immunocyte infiltration in colorectal cancer

CXCL8 induces M2 macrophage polarization and inhibits CD8+ T cell infiltration to generate an immunosuppressive microenvironment in colorectal cancer

PLA2G4A promotes right-sided colorectal cancer progression by inducing CD39+γδ Treg polarization

PD1 and CD39 expression on tumor infiltrating lymphocytes in patients with gastric cancer.

Multiplexed single-cell analysis reveals prognostic and nonprognostic T cell types in human colorectal cancer

Tumor-infiltrating Regulatory T Cells: Origins and Features

Colorectal Tumors Are Enriched with Regulatory Plasmablasts with Capacity in Suppressing T Cell Inflammation.